Skip to main content
Market intelligence
AVLNHealthcare

Avalyn Pharma Inc insider activity

In the last 90 days, 4 corporate insiders purchased $34,999,974 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$34,999,974
Corporate buyers
4
Latest transaction
May 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 1, 2026Novo Holdings A/s10% OwnerOpen Market Purchase555,555$18.00$9,999,990
May 1, 2026Jill CarrollDirectorOpen Market Purchase277,778$18.00$5,000,004
May 1, 2026Simeon George10% OwnerOpen Market Purchase555,555$18.00$9,999,990